not tagged
not tagged
[]
fascinating late-breaking clinical trials this am. just presented: a study assessing if causal ai can translate polygenic risk for cad into clinically actionable info (how much to lower ldl, systolic bp) to overcome a patient s polygenic risk of cv events. #acc2023 #accinnovation 
Cardiology Fellow at Stanford. Hopkins MD, Harvard MBA, Columbia IM residency. Formerly at Moderna Therapeutics, HealthReveal, and Flare Capital.